Altogether, miR-30e qualifies to combat bacterial replication by enhancing innate immunity via targeting SOCS1 and SOCS3, two crucial negative regulators of innate immune signaling cascade during bacterial infections. Here, SOCS3 is linked to bacterial infectious disease.